Gemifloxacin Can Partially Overcome Quinolone Resistance of H. pylori with gyrA Mutation in Taiwan

被引:20
作者
Chang, Wei-Lun [1 ,2 ]
Kao, Cheng-Yen [3 ]
Wu, Chung-Tai [1 ]
Huang, Ay-Huey [4 ]
Wu, Jiunn-Jong [5 ]
Yang, Hsiao-Bai [6 ]
Cheng, Hsiu-Chi [1 ]
Sheu, Bor-Shyang [1 ,2 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Basic Med Sci, Tainan 70101, Taiwan
[4] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70101, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan
[6] Ton Yen Gen Hosp, Dept Pathol, Hsinchu, Taiwan
关键词
Fluoroquinolone resistance; gemifloxacin; gyrA mutation; H; pylori; HELICOBACTER-PYLORI; ANTIBIOTIC-RESISTANCE; FLUOROQUINOLONE RESISTANCE; SEQUENTIAL THERAPY; RANDOMIZED-TRIAL; TRIPLE THERAPY; LEVOFLOXACIN; STRAINS; CLARITHROMYCIN; SITAFLOXACIN;
D O I
10.1111/j.1523-5378.2012.00935.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Backgrounds: The levofloxacin resistance caused by gyrA gene mutation is rising rapidly to limit wide application for Helicobacter pylori eradication. We investigated whether gemifloxacin has a superior antimicrobial activity to levofloxacin against H. pylori. Materials and Methods: Forty-four consecutive clinical H. pylori isolates with levofloxacin resistance and 80 randomly selected levofloxacin-sensitive controls were tested for gemifloxacin sensitivity by E-test. The resistance to levofloxacin or gemifloxacin was defined as minimal inhibitory concentration (MIC) > 1 mg/ L. The clinical features and GyrA mutation patterns checked by direct sequencing were also analyzed to assess its association with the H. pylori gemifloxacin resistance. Results: All levofloxacin-sensitive H. pylori isolates were sensitive to gemifloxacin. Eight strains (18.2%) resistant to levofloxacin could be still sensitive to gemifloxacin. Gemifloxacin achieved a 5-time lower in MIC levels against levofloxacin-resistant isolates. Nearly all levofloxacin-resistant isolates (97.7%, 43 / 44) had GyrA mutation at amino acid position 87 or 91. Double mutation sites may play dual roles in quinolone resistance, as N87K plus H57Y or D91N plus V77A mutations showed high-level resistance to both quinolones; whereas D91Y plus A97V or D91N plus A97V mutations showed low level levofloxacin resistance to become sensitive to gemifloxacin. In H. pylori isolates with single N87K, D91Y or D91N mutation, near 20% was gemifloxacin-sensitive and levofloxacin-resistant. The gemifloxacin- resistant rate of H. pylori was higher in patients with gastric ulcer than in those without (p <. 05). Conclusion: Gemifloxacin is superior to levofloxacin in antimicrobial activity against clinical H. pylori isolates, and even overcome some levofloxacin resistance.
引用
收藏
页码:210 / 215
页数:6
相关论文
共 26 条
[1]
Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium [J].
Bogaerts, Pierre ;
Berhin, Catherine ;
Nizet, Henri ;
Glupczynski, Youri .
HELICOBACTER, 2006, 11 (05) :441-445
[2]
Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) [J].
Cabrita, J ;
Oleastro, M ;
Matos, R ;
Manhente, A ;
Cabral, J ;
Barros, R ;
Lopes, AI ;
Ramalho, P ;
Neves, BC ;
Guerreiro, AS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1029-1031
[3]
Update on fluoroquinolone resistance in Helicobacter pylori:: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility [J].
Cattoir, Vincent ;
Nectoux, Juliette ;
Lascols, Christine ;
Deforges, Lionel ;
Delchier, Jean-Charles ;
Megraud, Francis ;
Soussy, Claude-James ;
Cambau, Emmanuelle .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (04) :389-396
[4]
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan [J].
Chang, Wei-Lun ;
Sheu, Bor-Shyang ;
Cheng, Hsiu-Chi ;
Yang, Yao-Jong ;
Yang, Hsiao-Bai ;
Wu, Jiunn-Jong .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (07) :1230-1235
[5]
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy [J].
Cheng, Hsiu-Chi ;
Chang, Wei-Lun ;
Chen, Wei-Ying ;
Yang, Hsiao-Bai ;
Wu, Jiunn-Jong ;
Sheu, Bor-Shyang .
HELICOBACTER, 2007, 12 (04) :359-363
[6]
Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK [J].
Chisholm, Stephanie A. ;
Owen, Robert J. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (10) :1322-1328
[7]
Systematic review and meta-analysis:: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure [J].
Gisbert, JP ;
De La Morena, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (01) :35-44
[8]
Helicobacter pylori treatment in the era of increasing antibiotic resistance [J].
Graham, David Y. ;
Fischbach, Lori .
GUT, 2010, 59 (08) :1143-1153
[9]
Prevalence of Primary Fluoroquinolone Resistance Among Clinical Isolates of Helicobacter pylori at a University Hospital in Southern Taiwan [J].
Hung, Kuei-Hsiang ;
Sheu, Bor-Shyang ;
Chang, Wei-Lun ;
Wu, Hsiu-Mei ;
Liu, Chin-Cheng ;
Wu, Jiunn-Jong .
HELICOBACTER, 2009, 14 (01) :61-65
[10]
Kese D, 2009, HEPATO-GASTROENTEROL, V56, P925